Skip to content

Announcements

DateTitle
21 Nov 24, 10:21Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements

View

10 Oct 24, 10:25Mydecine Innovations Group Inc - Suspension of Trading

View

22 Aug 24, 12:10Mydecine Innovations Group Inc - MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM FINANCIAL STATEMENTS

View

08 Jul 24, 07:00Mydecine Innovations Group Inc - Annual and Q1 Financial Statements

View

14 Jun 24, 07:00Mydecine Innovations Group Inc - Doc re: Bl-Weekly Status Report

View

03 Jun 24, 07:00Mydecine Innovations Group Inc - Bl-Weekly Status Report

View

17 May 24, 07:00Mydecine Innovations Group Inc - Mydecine Provides Bl-Weekly Status Report

View

03 May 24, 09:36Mydecine Innovations Group Inc - Mydecine applies for management cease trade order

View

03 May 24, 07:10Mydecine Innovations Group Inc - Management cease trade order

View

03 May 24, 07:00Mydecine Innovations Group Inc - Restructuring transactions and annual general and special meeting

View

30 Apr 24, 17:29Mydecine Innovations Group Inc - Total Voting Rights

View

16 Apr 24, 07:00Mydecine Innovations Group Inc - Closing of Share for Debt Settlement

View

09 Apr 24, 07:00Mydecine Innovations Group Inc - SHARE FOR DEBT SETTLEMENT

View

28 Mar 24, 07:10Mydecine Innovations Group Inc - Total Voting Rights

View

28 Mar 24, 07:00Mydecine Innovations Group Inc - Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement

View

21 Mar 24, 07:00Mydecine Innovations Group Inc - Share for Debt Settlement

View

01 Mar 24, 09:01Mydecine Innovations Group Inc - Total Voting Rights

View

23 Feb 24, 07:00Mydecine Innovations Group Inc - Closing of Share for Debt Settlement

View

08 Feb 24, 07:00Mydecine Innovations Group Inc - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

View

02 Feb 24, 07:00Mydecine Innovations Group Inc - Mydecine Innovations Group Announces Director Resignation

View


Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers
ISO 27001 Certified

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal